Skip to main content

Table 1 Micturition parameters baseline and after treatment (mean values and range)

From: Re-implantation after insufficient primary 125-i permanent prostate brachytherapy

Number of patients RI / control

Baseline 5 / 137

6 weeks 5 / 136

6 months 5 / 142

1 year 4 / 130

2 years 3 / 115

3 years 2 / 90

Residual urine (ml) Control:

0 [0-0] 23.3 [0-300]

48 [20-80] 55.8 [0-900]

58 [20-90] 39.8 [0-400]

32.5 [0-100] 24 [0-200]

18 [6-30] 16.1 [0-122]

0 [0-0] 17.4 [0-200]

Residual urine (ml/s) Control:

20.8 [16.1-32] 18.5 [5.5-40]

15.2 [10.3-18.8] 11.1 [7-26]

11.6 [9.4-14.1] 12.6 [3.3-35]

16.3 [13.5-19] 14.6 [4.1-35.7]

20.4 [18.4-24.1] 16.1 [3.8-40]

19.8 [17.4-22.1] 15.1 [2.2-34.8]

IPSS Control:

5.7 [3-11] 5.8 [0-22]

11.7 [7-19] 15.3 [1-34]

14.3 [11-19] 12.7 [0-34]

12.3 [7-15] 10.3 [1-26]

9.0 [6-12] 9.5 [0-26]

6.5 [4-9] 7.5 [1-28]

IPSS-QoL Control:

0.7 [0-1] 0.96 [0-5]

2.7 [1-4] 2.6 [0-6]

2.5 [1-4] 2.2 [0-6]

2.3 [1-4] 1.7 [0-6]

2.0 [1-3] 1.5 [0-5]

2.0 [1-3] 1.2 [0-5]

  1. As control, mean values of 144 consecutive patients treated without re-implantation are shown. The first line shows the values for the re-implanted patients, the second the control group consisting of patients not receiving a re-implantation. (IPSS data was available for 3,3,4,3,2,2 patients respectively).